15 LISI - 2024 Integrated Report Additionally, significant efforts have been made over the past two years to raise awareness among our teams on these issues — first focusing on technical aspects and then on human factors. In 2024, all of our employees received comprehensive HSE (Health, Safety, and Environment) training. What progress are you making on environmental issues? We have met the commitments we set for ourselves, achieving a 2% reduction in energy consumption in 2024 compared to the previous year. The actions implemented, primarily at our French sites in Neyron and Hérouville, in Calvados, are beginning to show results. Additionally, we have launched a plan to install solar panels at both Neyron and Hérouville. Our goal is to internally produce approximately 3% of our electricity consumption by 2030. Do you also have ambitious goals for increasing female representation? We have indeed focused heavily on employing more women, which is a key priority for us. Our goal is to eventually reach 30% women in management positions across the division. To achieve this, we are raising awareness among young people about technical careers that currently have low female representation. We are also exploring ways to improve the work environment, address motivations, and create development opportunities to attract female candidates to highly technical projects. The transformation of our sites into highly technological production organizations, with Industry 4.0-style processes, supports these efforts and is helping to reignite young people’s interest in the industrial sector. How did the markets perform in 2024? LISI MEDICAL remains firmly positioned in its two major markets: on one side, orthopedics, which focuses on the manufacturing of implants and joint prostheses, and on the other, the market for minimally invasive surgical (MIS) instruments. For both businesses, 2024 was a year of stability following two years of strong growth. However, the balance between these two markets has shifted. The MIS segment experienced a slight slowdown as clients, implementing their post-COVID strategies, opted to rebuild inventories for most programs where we were involved. Conversely, orthopedics saw significant growth, driven particularly by the development of our primary client, who achieved the highest market growth this year thanks to innovations in surgical processes that provide a real advantage. This positive momentum has been especially beneficial for us and offsets the slowdown in MIS activity. You’ve achieved excellent results in workplace safety. How do you explain this? Two of our sites achieved excellent results in 2024, with more than 2,000 days without accidents at Neyron, in Ain, France, and nearly 800 days at Coon Rapids, Minnesota, in the United States. We launched a comprehensive safety plan, which included compliance analyses and corrective measures for all machine tools across the division to enhance employee safety. Interview Lionel Rivet CEO LEARN MORE The transformation of our sites into highly technological organizations, resembling Industry 4.0 factories, is reigniting young people’s interest in the industrial sector”
RkJQdWJsaXNoZXIy MTEyMTU=